Sakai Chemical Industry Co Ltd (SCI) is primarily involved in the manufacturing and sale of chemical industrial products and pharmaceuticals. The company serves various industries, including electronics, cosmetics, medical, and construction. The company carries out business operations through its domestic and international subsidiaries. Its main products include titanium dioxide, barium and strontium products, plastic additives, zinc oxide, catalysts, electronic materials, cosmetic raw materials, pharmaceuticals, organic chemical products and road marking products, among others. Titanium dioxide is used in a wide range of applications, including paints, printer inks, paper manufacturing, plastics, chemical fibers, rubber, porcelain enamel, optical glass and capacitors. It provides zinc oxide which is used wide range of applications including paint, rubber, plastic, cosmetics and electronic materials, among others.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

SCI had initiated several R&D initiatives, including the trial implementation of a cloud-based Materials Informatics (MI) platform to promote innovation and improve the efficiency and speed of research and development. The company is focusing on the early commercialization of Smart Materials and enhancing operational efficiency at its plants. Additionally, the company is strengthening its production system for small-molecule APIs and intermediates, pursuing technological innovation in pharmaceutical manufacturing and organic synthesis, and promoting the introduction of generative AI to improve internal operations. The company is also addressing communication challenges between management and employees and revising its human resources system to attract and support talented individuals. The R&D unit of the company is the Research and Development Division, which is responsible for trial implementation of the MI platform, accumulating and sharing technical knowledge, and promoting innovation across departments and sites. In FY2025, the company spent JPY2,699 million on R&D, compared to R&D of JPY2,722 million in the previous year, which as a percentage of revenue, stood at 3.1%.